In this study, we investigate the contribution of BET proteins, especially BRD4, to the immune-suppressive functions of MDSCs and assess whether targeting BET proteins with OPN5 can alleviate MDSC-mediated immune suppression in preclinical models of CLL. The gene discussed is DNER; the disease is B-cell chronic lymphocytic leukemia.